In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Calypso, Varian combine cancer tech:

This article was originally published in Clinica

Executive Summary

Tumour detection specialist Calypso Medical has announced plans to combine its Calypso 4D Localization System with Varian Medical Systems' treatment planning system and linear accelerators to enhance radiotherapy treatment. The 4D system, which Calypso (Seattle, Washington) claims is the first device to use a non-ionizing approach for target localisation in treatment setup and monitoring during radiation therapy delivery, aims to give clinicians improved patient positioning, motion management and tumour targeting when integrated with Varian's Eclipse and On Board Imager technologies. Integration of the 4D system and Eclipse is expected to begin after the 4D's launch - it received FDA 510(k) clearance for use in prostate therapy only in July 2006.






Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts